Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Neuropace Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
NPCE
Nasdaq
3845
https://www.neuropace.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Neuropace Inc
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
- Apr 17th, 2024 8:05 pm
‘Time to Hit Buy,’ Says Wells Fargo About These 2 Stocks
- Apr 4th, 2024 4:20 pm
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
- Mar 27th, 2024 8:05 pm
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 4:44 pm
NeuroPace Full Year 2023 Earnings: EPS Beats Expectations
- Mar 7th, 2024 10:07 am
Q4 2023 Neuropace Inc Earnings Call
- Mar 6th, 2024 11:28 am
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
- Mar 5th, 2024 9:05 pm
Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio
- Mar 5th, 2024 7:00 pm
20 Most Valuable Digital Health Companies In The US
- Feb 23rd, 2024 10:15 am
NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
- Feb 15th, 2024 9:05 pm
NeuroPace Inc Chief Medical Officer Martha Morrell Sells 17,589 Shares
- Feb 7th, 2024 8:13 am
NeuroPace Inc Chief Medical Officer Martha Morrell Sells 13,848 Shares
- Feb 2nd, 2024 4:02 am
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates
- Jan 8th, 2024 12:03 pm
NeuroPace Inc Chief Medical Officer Martha Morrell Sells 13,402 Shares
- Dec 30th, 2023 2:01 am
NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
- Dec 21st, 2023 12:07 pm
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Dec 19th, 2023 9:30 pm
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
- Dec 4th, 2023 10:07 pm
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
- Dec 1st, 2023 1:00 pm
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
- Nov 21st, 2023 1:00 pm
NeuroPace, Inc. (NASDAQ:NPCE) Q3 2023 Earnings Call Transcript
- Nov 7th, 2023 2:45 pm
Scroll